Makela Jan's Form 4 filing
GE HealthCare Technologies Inc.GEHC · filed Mar 16, 2023
- Accession no.
- 0001951803-23-000003
- Filed
- Mar 16, 2023
- Trade date
- Mar 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $5.49M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Makela JanCIK 0001951803 | Officer (CEO, Imaging) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +240 | $63.51 | +$15,242.4 | 69,720 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +5,967 | $57.74 | +$344,534.58 | 75,687 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +54,701 | $40.40 | +$2,209,920.4 | 130,388 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +4,037 | $51.67 | +$208,591.79 | 134,425 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | SSaleDisposed | −64,945 | $77.66F1 | −$5,043,628.7 | 69,480 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | SSaleDisposed | −5,684 | $78.07F2 | −$443,749.88 | 63,796 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseDisposed | −240 | $0.00 | $0 | 0 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseDisposed | −5,967 | $0.00 | $0 | 0 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseDisposed | −54,701 | $0.00 | $0 | 0 | Direct | |
| Mar 14, 2023 | Common Stock, par value $0.01 per share | MOption exerciseDisposed | −4,037 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.89 to $78.28, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
Referenced by the price of 1 transaction in Table I.
- F2
The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.95 to $78.23, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
Referenced by the price of 1 transaction in Table I.